Key result
Inhibition of RAGE with FPS-ZM1 prevented the impairment of flow-mediated dilation caused by acute and sub-acute exposure to e-cigarette aerosols and cigarette smoke in rats.
Why the study?
Although e-cigarettes cause detrimental cardiovascular alterations, the molecular mechanism of e-cigarette-induced vascular impairment remains relatively unexplored.
Does RAGE inhibition prevent e-cigarette-induced impairment of endothelial vasodilation in rats?
Does RAGE inhibition prevent e-cigarette-induced impairment of endothelial vasodilation in rats?
RAGE inhibition prevents acute and sub-acute impairment of endothelial vasodilatory function induced by e-cigarette aerosol and cigarette smoke in a rat model.
Preclinical RAGE inhibition preserves endothelial function after e-cigarette exposure in rats; leaves open translation to human vascular effects.
Introduction: Although e-cigarette is known to cause detrimental physiological alterations in the cardiovascular system, the molecular mechanism of e-cigarette-induced vascular impairment is relatively unexplored. We investigated whether the inhibition of RAGE prevents impairment of vasomotor function from acute and chronic e-cigarette exposure. Hypothesis: RAGE is required to cause e-cigarette-induced impairment of endothelial vasodilation. Methods: In both exposure settings, anaesthetized rats (n=8/group) were exposed to aerosols from flavorless tank-style e-cigarettes with and without freebase nicotine (12 mg/mL) or air. For acute exposure, exposure was done in a singles session of 10 cycles of pulsatile 5s exposure over 5 minutes using a Gram REsearch analytical vaping machine drawing 55ml. All rats received RAGEi or DMSO i.p. 1h pre-exposure. FMD was measured pre-exposure and 10 minutes after the end of the exposure. For sub-acute exposure, the exposure consisted of a single session of 120 cycles of pulsatile 5s exposure over 1h/day for 2 weeks. All the rats received RAGEi or DMSO i.p. 1h pre-exposure daily during acclimation and exposure (total of 3 weeks). Echocardiography was conducted one day before the end of the experiment. FMD was measured before and after the exposure on the last day of the experiment. Results: Exposure to e-cigarette aerosol with and without nicotine impaired FMD in vehicle groups in both acute and subacute exposures with no change in air control. As expected, the positive control of cigarette exposure impaired FMD in the vehicle group in acute settings. However, FPS-ZM1 prevented the FMD impairment in e-cigarette aerosol exposures and cigarette exposures in both acute and subacute exposures with no changes in air control. Conclusions: RAGE plays a role in mediating e-cigarette-induced acute and sub-acute impairment of endothelial vasodilatory function.
No takes yet. Share an insight, caveat, or question.
Han et al. (2023) studied e-cigarette-induced vascular impairment. RAGE inhibitor (FPS-ZM1) vs. DMSO (vehicle) was evaluated on Flow-mediated dilation (FMD). Inhibition of RAGE with FPS-ZM1 prevented the impairment of flow-mediated dilation caused by acute and sub-acute exposure to e-cigarette aerosols and cigarette smoke in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: